ScreenerHero
PXSProvexis plc
LSE · GB · Healthcare · Drug Manufacturers - Specialty & Generic · provexis.com
1.125GBP+3.21%Mkt Cap: 33.85M $P/E: —

Provexis plc, together with its subsidiaries, develops, licenses, and sells functional foods, medical foods, and dietary supplements worldwide. The company offers syrup and powder versions of Fruitflow, a tomato extract …

Industry Peers

Drug Manufacturers - Specialty & Generic
Screen all
MRK
Merck KGaA
$65.19BUSDP/E 23.7
HLN
Haleon plc American Depositary Shares (Each representing two Ordinary Shares)
$43.41BUSDP/E 20.1
ZOE
Zoetis Inc.
$29.89BUSDP/E 12.7
UTHR
United Therapeutics Corporation
$22.70BUSDP/E 19.0
VTRS
Viatris, Inc.
$18.66BUSD
SOBI
Swedish Orphan Biovitrum AB
$15.39BUSDP/E 118.0
NBIX
Neurocrine Biosciences, Inc.
$15.81BUSDP/E 22.8
IPN
Ipsen S.A.
$14.67BUSDP/E 26.4
ELAN
Elanco Animal Health Incorporat
$12.24BUSD
KRK
Krka, d. d.
$8.57BUSDP/E 18.8
HIMS
Hims & Hers Health, Inc.
$7.25BUSD
LQDA
Liquidia Corporation
$6.74BUSDP/E 53.8
LNTH
Lantheus Holdings Inc
$6.56BUSDP/E 24.0
AMRX
Amneal Pharmaceuticals, Inc.
$6.23BUSDP/E 37.3
INDV
Indivior PLC Ordinary Shares
$4.61BUSDP/E 14.0
HIK
Hikma Pharmaceuticals PLC
$4.32BUSDP/E 12.5
AMLX
Amylyx Pharmaceuticals Inc. Common Stock
$4.30BUSD
SFZN
Siegfried Holding AG
$3.91BUSDP/E 20.4
ROVI
Laboratorios Farmaceuticos Rovi, S.A.
$3.32BUSDP/E 16.5
SUPN
Supernus Pharmaceuticals, Inc.
$2.82BUSD

Key Statistics

Company
Market Cap33.85M $
Enterprise Value32.49M $
Revenue (TTM)1.12M $
Gross Profit683.55K $
Net Income (TTM)-580.66K $
Revenue/Share0.0000 USD
Last Price1.125 GBP
Fiscal Year EndMar 2025
MR QuarterSep 2025
Employees2
CountryGB
SectorHealthcare
IndustryDrug Manufacturers - Specialty & Generic
ISIN—
Valuation
P/E (Trailing)—
P/E (Forward)—
PEG—
EV/EBITDA—
EV/Revenue29.08
P/S30.96
P/B—
EPS (TTM)0.00
EPS (Forward)—
52W Range
0.006272% of range1.550
52W High1.550 GBP
52W Low0.0062 GBP
Profitability
Gross Margin41.24%
Oper. Margin-85.00%
EBITDA Margin0.00%
Profit Margin-35.03%
ROE-34.89%
ROA-44.73%
Growth
Revenue Growth-53.60%
Earnings Growth—
Cash Flow & Leverage
Operating CF-437.15K $
CapEx (TTM)—
FCF Margin-37.23%
FCF Yield-1.23%
Net Debt-671.25K $
Net Debt/EBITDA—
Balance Sheet
Debt/Equity—
Current Ratio3.65
Quick Ratio3.46
Book Value/Sh0.0000 GBP
Cash/Share0.0000 GBP
Dividends
Fwd Div Rate—
Trail. Div Rate0.0000 GBP
Div. Yield—
5Y Avg Yield—
Payout Ratio0.00%
Ex-Div Date—
Pay Date—
Splits
Last Split2:1
Split DateJun 23, 2005
Analyst Consensus
Rating—
Target (Mean)—
Target Range—
# Analysts—
Ownership
Shares Out.2.35B
Float1.81B
Insiders20.84%
Institutions9.87%
Technical
SMA 501.165 (-3.4%)
SMA 2001.036 (+8.6%)
Beta0.66
S&P 52W Chg18.16%
Avg Vol (30d)941.42K
Avg Vol (10d)748.08K
Technical Indicators
RSI (14)48.5
MACD-0.0182
MACD Signal-0.0174
MACD Hist.-0.0008
BB Upper1.234 GBP
BB Middle1.135 GBP
BB Lower1.035 GBP
BB Width17.51%
ATR (14)0.1907 GBP
Vol Ratio (20d)0.27x